Intratumoral therapy – in which cancer drugs are injected directly into tumors – is a promising treatment option for solid cancers but has shown limited success in clinical trials due to an inability to precisely deliver the drug and because most immunotherapies quickly dissipate from the site of injection.
MDLive veterans nab $7.5M Series A for virtual specialty care startup
(This story is from our Health Tech newsletter. If you’d like to sign up, just click here.) Circadian Health, a startup … Sign up to
September 6, 2024